| scholarly article | Q13442814 |
| P50 | author | Thomas Ten Have | Q57327797 |
| Daniel A Weintraub | Q64767919 | ||
| Matthew B. Stern | Q67208124 | ||
| P2093 | author name string | Amy Colcher | |
| Howard I Hurtig | |||
| John E Duda | |||
| Paul J Moberg | |||
| Sarra Nazem | |||
| Andrew D Siderowf | |||
| Jayne R Wilkinson | |||
| Stacy S Horn | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 | ||
| Using the Mini-Mental State Examination for tracking cognition in the older population based on longitudinal data | Q31117597 | ||
| Population-based norms for the Mini-Mental State Examination by age and educational level | Q34363883 | ||
| Diagnostic criteria for Parkinson disease | Q34489839 | ||
| Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease | Q35040826 | ||
| Cognitive impairment in Parkinson's disease | Q36226772 | ||
| Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. | Q36834550 | ||
| Clinical diagnostic criteria for dementia associated with Parkinson's disease | Q36836828 | ||
| Dementia and cognitive impairment in Parkinson's disease. | Q42088658 | ||
| The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease | Q43481961 | ||
| The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study | Q44171532 | ||
| The meaning of cognitive impairment in the elderly | Q44556333 | ||
| Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial | Q46853430 | ||
| Assessment of cognition in Parkinson's disease. | Q47392996 | ||
| Defining mild cognitive impairment in Parkinson's disease | Q48212869 | ||
| Dementia in Parkinson disease: a neuropsychological analysis | Q49083788 | ||
| A longitudinal study of neuropsychological change in individuals with Parkinson's disease. | Q50481908 | ||
| A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. | Q51896723 | ||
| Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. | Q51916987 | ||
| Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). | Q51930615 | ||
| Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. | Q51949961 | ||
| Neuropsychological profile of patients with Parkinson's disease without dementia. | Q51950566 | ||
| The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. | Q51985663 | ||
| Visual dysfunction in Parkinson disease without dementia. | Q51987311 | ||
| Cognitive profile of patients with newly diagnosed Parkinson disease. | Q51987773 | ||
| Memory and executive function impairment predict dementia in Parkinson's disease. | Q52009084 | ||
| Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people | Q77780064 | ||
| Fluctuations in attention: PD dementia vs DLB with parkinsonism | Q78633355 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 304-308 | |
| P577 | publication date | 2008-12-10 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score | |
| P478 | volume | 57 |
| Q50090251 | A model-based quantification of action control deficits in Parkinson's disease |
| Q30467565 | A randomized controlled trial of an enhanced interdisciplinary community based group program for people with Parkinson's disease: study rationale and protocol |
| Q34300160 | A recommended scale for cognitive screening in clinical trials of Parkinson's disease |
| Q34270330 | Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates |
| Q58781363 | Abnormal Spontaneous Brain Activity in Early Parkinson's Disease With Mild Cognitive Impairment: A Resting-State fMRI Study |
| Q38379419 | Action-semantic and syntactic deficits in subjects at risk for Huntington's disease. |
| Q38571668 | Advances in the treatment of cognitive impairment in Parkinson's disease |
| Q48758498 | Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients |
| Q34235570 | Association between cognition and function in patients with Parkinson disease with and without dementia |
| Q36608943 | Autonomy of patients with type 2 diabetes with an insulin pump device: is it predictable? |
| Q48364332 | Brain activation pattern related to gait disturbances in Parkinson's disease |
| Q50767430 | Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. |
| Q37161441 | Can we improve clinical prediction of at-risk older drivers? |
| Q42744489 | Changes of brain gray matter structure in Parkinson's disease patients with dementia |
| Q43843579 | Changes on brief cognitive instruments over time in Parkinson's disease |
| Q38863643 | Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease |
| Q35199149 | Clinical heterogeneity in patients with early-stage Parkinson's disease: a cluster analysis |
| Q48172009 | Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments |
| Q56526159 | Cognitive characteristics in Chinese non-demented PD patients based on gender difference |
| Q37968511 | Cognitive impairment in nondemented Parkinson's disease |
| Q36800297 | Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan |
| Q47741627 | Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment |
| Q92527844 | Comparing the Diagnostic Accuracy of Two Cognitive Screening Instruments in Different Dementia Subtypes and Clinical Depression |
| Q90319843 | Comparing the Mini-Mental State Examination and the modified Mini-Mental State Examination in the detection of mild cognitive impairment in older adults |
| Q55420221 | Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms. |
| Q45889593 | Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson's disease |
| Q35211543 | Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease |
| Q33734416 | Correlation of sleep disturbance and cognitive impairment in patients with Parkinson's disease |
| Q83774128 | Dementia in Parkinson's disease |
| Q41691324 | Depression and social phobia in essential tremor and Parkinson's disease |
| Q89179884 | Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison |
| Q50625913 | Development of the Thai version of Mini-Cog, a brief cognitive screening test. |
| Q50750569 | Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA. |
| Q37346596 | Differences in cognitive profiles between traumatic brain injury and stroke: A comparison of the Montreal Cognitive Assessment and Mini-Mental State Examination |
| Q48167887 | Drivers with Parkinson's disease: are the symptoms of PD associated with restricted driving practices? |
| Q64869751 | Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention |
| Q34565375 | Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial |
| Q27313934 | Effects of Group, Individual, and Home Exercise in Persons With Parkinson Disease: A Randomized Clinical Trial |
| Q33593224 | Emergence and evolution of social self-management of Parkinson's disease: study protocol for a 3-year prospective cohort study |
| Q89960781 | Establishment of a Risk Prediction Model for Mild Cognitive Impairment among Elderly Chinese |
| Q37514014 | Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease? |
| Q36712378 | Experiential and Doctrinal Religious Knowledge Categorization in Parkinson's Disease: Behavioral and Brain Correlates. |
| Q38675271 | Frontal Assessment Battery in Parkinson's Disease: Validity and Morphological Correlates. |
| Q46912801 | Gait and Cognition in Parkinson's Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task |
| Q35881786 | Genetic influences on cognitive decline in Parkinson's disease |
| Q47423910 | Global scales for cognitive screening in Parkinson's disease: Critique and recommendations |
| Q51105542 | Grooved pegboard predicates more of cognitive than motor involvement in Parkinson's disease. |
| Q34128695 | Health-Related Quality of Life in Parkinson disease: Correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans |
| Q36733335 | Hemispheric asymmetry of electroencephalography-based functional brain networks |
| Q47312949 | Home-based step training using videogame technology in people with Parkinson's disease: a single-blinded randomised controlled trial. |
| Q50558969 | Immediate effects of adding mental practice to physical practice on the gait of individuals with Parkinson's disease: Randomized clinical trial. |
| Q50243244 | Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication |
| Q51808876 | Impulse control disorders in Parkinson disease: a multicenter case--control study. |
| Q37273066 | Influence of aerobic exercise training on the neural correlates of motor learning in Parkinson's disease individuals. |
| Q47608273 | Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease |
| Q35234522 | MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. |
| Q35000195 | Measuring cognition: the Chicago Cognitive Function Measure in the National Social Life, Health and Aging Project, Wave 2. |
| Q82552215 | Mild cognitive impairment in Parkinson's disease |
| Q50737231 | MoCA as a Screening Tool of Neuropsychological Deficits in Alcohol-Dependent Patients. |
| Q64239120 | Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination |
| Q37679384 | Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease |
| Q38756805 | Multicenter Validation of an MMSE-MoCA Conversion Table |
| Q30538175 | Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy |
| Q36183262 | Neuropsychological profile in Chinese patients with Parkinson's disease and normal global cognition according to Mini-Mental State Examination Score |
| Q37653496 | Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm |
| Q35201409 | Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease |
| Q30248574 | Parkinson Disease and Dementia |
| Q37825631 | Parkinson's disease dementia and potential therapeutic strategies |
| Q37739308 | Parkinson's disease dementia. |
| Q36186763 | Parkinson's disease dementia: a neural networks perspective |
| Q33874635 | Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research |
| Q30586896 | People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance |
| Q64768975 | Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson's disease dementia: screen, test and then diagnose |
| Q47668695 | Prediction of geriatric rehabilitation outcomes: Comparison between three cognitive screening tools |
| Q37329479 | Predictors of cognitive decline in the early stages of Parkinson's disease: a brief cognitive assessment longitudinal study. |
| Q34531319 | Predictors of cognitive impairment in an early stage Parkinson's disease cohort |
| Q47198236 | Progression in the LRRK2-Asssociated Parkinson Disease Population |
| Q50643300 | Pulsion severity showed a good correlation with cognitive function in Parkinson's disease. |
| Q35131210 | Rapid cognitive screening of patients with substance use disorders |
| Q48259289 | Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study |
| Q36035069 | Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults |
| Q35712099 | Reliability and Validity of the Beijing Version of the Montreal Cognitive Assessment in the Evaluation of Cognitive Function of Adult Patients with OSAHS. |
| Q57089620 | SIMPLIFYING DETECTION OF MILD COGNITIVE IMPAIRMENT SUBTYPES |
| Q35674661 | Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease. |
| Q36082655 | Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting |
| Q36253870 | Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale |
| Q36304622 | Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests |
| Q50618045 | Screening for cognitive impairment in a Chinese ALS population. |
| Q46683875 | Screening for mild cognitive impairment in patients with heart failure: Montreal cognitive assessment versus mini mental state exam. |
| Q44402270 | Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE? |
| Q90752580 | Self-reported rates of impulsivity in Parkinson's Disease |
| Q37629567 | Sexual dimorphism in Parkinson's disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
| Q36262069 | Side-of-onset of Parkinson's disease in relation to neuropsychological measures. |
| Q36076655 | Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease |
| Q47114217 | Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease |
| Q50600799 | Susceptibility to retroactive interference: The effect of context as a function of age and cognition. |
| Q44518757 | The Montreal Cognitive Assessment (MoCA) in geriatric rehabilitation: psychometric properties and association with rehabilitation outcomes. |
| Q51021413 | The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. |
| Q46895306 | The Montreal Cognitive Assessment in persons with traumatic brain injury |
| Q48365769 | The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder |
| Q47883563 | The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder |
| Q42840532 | The improvement of cognitive functions in patients with bronchial asthma after therapy |
| Q48951847 | The mini-mental state examination and the Montreal Cognitive Assessment after traumatic brain injury: an early predictive study |
| Q39313320 | The relative contribution of physical and cognitive fall risk factors in people with Parkinson's disease: a large prospective cohort study. |
| Q38206495 | The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease |
| Q92517953 | The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis |
| Q48053905 | Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease |
| Q33925218 | Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease |
| Q42343342 | Using the Folstein Mini Mental State Exam (MMSE) to explore methodological issues in cognitive aging research |
| Q33744548 | Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease |
| Q50801080 | Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease. |
| Q35124579 | Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA. |
| Q64866469 | Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients |
| Q50659742 | Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease. |
| Q51860172 | Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis. |
| Q48308554 | Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder |
| Q33516505 | Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease |
| Q45291627 | Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease |
| Q31097087 | Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data |
| Q46651245 | Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons? |
| Q35148870 | Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack |
Search more.